Tech Company Financing Transactions
Triomics Funding Round
General Catalyst, Lightspeed Venture Partners and Nexus Venture Partners participated in a $15 million capital raise for Triomics. The financing was announced on 5/9/2024.
Transaction Overview
Company Name
Announced On
5/9/2024
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
601 Montgomery St 1100
San Francisco, CA 94111
USA
San Francisco, CA 94111
USA
Phone
Undisclosed
Website
Email Address
Overview
We'd point to our leadership in creating a consortium of over 20 NCI-designated cancer centers, along with Ci4CC. The group, named the Collaboration for Oncology focused LLM Training (COLT), recognizes that generative AI is a nascent technology and oncology is a zero-fail space. We therefore partner together to share best practices, and determine performance benchmarks and safety standards.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sarim Khan
Chief Medical Officer
Daniel Novinson
Chief Technical Officer
Hrituraj Singh
Browse more venture capital transactions:
Prev: 5/9/2024: AgriDex venture capital transaction
Next: 5/9/2024: CoverTree venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs